Numerous insurers — including Oscar Health, Elevance Health, Molina Healthcare and Centene — have announced they're cutting or withdrawing their earnings guidance for the year. And the individual market seems to be the culprit.
HCA and Tenet reported net incomes for the second quarter, while CHS posted a net loss. All three health systems found themselves in a better financial position in Q2 2023 than they were in Q2 of last year, driven in large part by declining contract labor expenses.
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
As more companies spin up their own telehealth products, Teladoc CEO Jason Gorevic said the company continues to acquire and retain customers by having a full suite of solutions. He expects that point solutions will have a harder time going forward.
CVS lowered its guidance for vaccines after seeing vaccinations decline from their mid-April heights. But more people are coming in for first doses after the Delta variant has caused Covid-19 cases to rise again.
HCA Healthcare posted a $1.07 billion profit in the second quarter, despite a dropoff in patient volumes due to the cancelation of elective procedures. A large portion of that stemmed from relief funds allocated through the CARES Act.
Primary care startup One Medical saw a bigger net loss in its first earnings report since it went public. The company is making efforts to rein in costs in light of the pandemic, including delaying new office openings.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
UnitedHealth Group beat earnings expectations in the first quarter of 2020, bringing in $5 billion in profit. For now, the company is keeping its outlook for 2020 of earnings-per-share between $15.45 and $15.75, despite the uncertainty from the virus.
After going public last year, digital health startup Livongo saw its membership nearly double in 2019. The company saw significant uptake for its diabetes solution, a trend it expects to continue after striking several key partnerships.
Anthem Inc. saw Medicare Advantage enrollment increase more than 20% year-over-year. The company now has a total of 1.2 million members enrolled in Medicare Advantage plans, and expects to add another 150,000 to 200,000 members next year.
Teladoc recently released its first quarter 2017 financial results, reporting revenue of $42.9 million and a net loss of $15.7 million. CEO Jason Gorevic said the company "met or exceeded" guidance across all its key metrics.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Newly public telehealth service provider Teladoc saw substantial increases in revenue, membership and patient encounters during the second quarter, but also saw its financial losses widen.
Analysts who fear health spending is accelerating got plenty of evidence in Wall Street’s second-quarter results to support their thesis. But so did folks who hope spending is still under control. Now everybody’s trying to sort out the mixed message. The answer matters because deficit debates and affordability concerns revolve around forecasts that health spending will […]
Edwards LifeSciences Corp. reported a total revenue of $517 million for Q2, with 7.3 percent increased net sales, “driven by strong sales of transcatheter and surgical heart valves in both the U.S. and Europe,” CEO Michael Mussalem said. Combined, the two provided 16 percent of sales in the U.S., helped by the SAPIEN launch in the U.S.. […]
In announcing its fourth-quarter earnings Tuesday, Boston Scientific (NYSE:BSX) also announced that it was reducing its workforce by 900 to 1,000 people worldwide, a move that will lower pre-tax operating expenses by $100 million to $115 million by the end of the year. The reduction will occur through a mixture of attrition and layoffs. A […]
On Wednesday, St. Jude Medical CEO Dan Starks fielded a couple of questions related to its Durata ICD lead on its fourth-quarter earnings call, although there were none on a possible recall of the product, despite my expectations. The Durata ICD lead has been troubled by its association with a recalled, previous-generation ICD lead and […]